How neuropsychiatric comorbidity, modulatory indication, demographics, and other factors impact deep brain stimulation inpatient outcomes in the United States: A population-based study of 27,956 patients
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 208, 106842
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Regional trends and the impact of various patient and hospital factors on outcomes and costs of hospitalization between academic and nonacademic centers after deep brain stimulation surgery for Parkinson's disease: a United States Nationwide Inpatient Sample analysis from 2006 to 2010Neurosurgical Focus, 2013
- The current and projected economic burden of Parkinson's disease in the United StatesMovement Disorders, 2013
- The effect of centralization of caseload for primary brain tumor surgeries: trends from 2001–2007Acta Neurochirurgica, 2012
- Deep Brain Stimulation for Psychiatric DisordersAnnual Review of Neuroscience, 2011
- Essential tremor — Neurodegenerative or nondegenerative disease towards a working definition of ETMovement Disorders, 2009
- Disrupting Disordered Neurocircuitry: Treating Refractory Psychiatric Illness With NeuromodulationMayo Clinic Proceedings, 2009
- Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled TrialJAMA, 2009
- Stimulating personality: Ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposesBiotechnology Journal, 2008
- Deep Brain Stimulation for Neurologic and Neuropsychiatric DisordersNeuron, 2006
- Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: The effect of provider caseload and centralization of careNeuro-Oncology, 2005